2005•Zhongguo yaofangRequires access

Study on Relative Bioavailability of Cefaclor Capsules in Human Body

Zhao Xu-yuan

Open publisher page 0 citations

Abstract

OBJECTIVE:To evaluate the relative bioavailability of2kinds of preparations of cefaclor capsules.METHˉODS:The subjects'blood concentrations were determined by HPLC at different time after administered randomly crossover with single oral dose of cefaclor testing preparation or reference preparation.The actual values of C max and T max were adopted;AUC was calculated by trapezoid planimetry;the bioequiavailability of the2preparations were evaluated by two-sides and one-side t-test.RESULTS:The AUC 0~4 of the testing preparation and reference preparation were respectively(13.44±3.06)(μg·h)/ml and(14.19±3.28)(μg·h)/ml;their respective AUC 0~∞ were(13.80±3.08)(μg·h)/ml and(14.62±3.33)(μg·h)/ml;their respective C max were(11.65±2.39)μg/ml and(12.37±2.41)μg/ml;their respective t max were(0.57±0.24)h and(0.66±0.19)h.The relative bioavailability of testing preparation was(95.62±13.51)%.CONˉCLUSION:The2preparations are bioequivalent.

About this research paper

What this paper is about

OBJECTIVE:To evaluate the relative bioavailability of2kinds of preparations of cefaclor capsules.METHˉODS:The subjects'blood concentrations were determined by HPLC at different time after administered randomly crossover with single oral dose of cefaclor testing preparation or reference preparation.The actual values of C max and T max were adopted;AUC was calculated by trapezoid planimetry;the bioequiavailability of the2preparations were evaluated by two-sides and one-side t-test.RESULTS:The AUC 0~4 of the testing preparation and reference preparation were respectively(13.44±3.06)(μg·h)/ml and(14.19±3.28)(μg·h)/ml;their respective AUC 0~∞ were(13.80±3.08)(μg·h)/ml and(14.62±3.33)(μg·h)/ml;their respective C max were(11.65±2.39)μg/ml and(12.37±2.41)μg/ml;their respective t max were(0.57±0.24)h and(0.66±0.19)h.The relative bioavailability of testing preparation was(95.62±13.51)%.CONˉCLUSION:The2preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To evaluate the relative bioavailability of2kinds of preparations of cefaclor capsules.METHˉODS:The subjects'blood concentrations were determined by HPLC at different time after administered randomly crossover with single oral dose of cefaclor testing preparation or reference preparation.The actual values of C max and T max were adopted;AUC was calculated by trapezoid planimetry;the bioequiavailability of the2preparations were evaluated by two-sides and one-side t-test.RESULTS:The AUC 0~4 of the testing preparation and reference preparation were respectively(13.44±3.06)(μg·h)/ml and(14.19±3.28)(μg·h)/ml;their respective AUC 0~∞ were(13.80±3.08)(μg·h)/ml and(14.62±3.33)(μg·h)/ml;their respective C max were(11.65±2.39)μg/ml and(12.37±2.41)μg/ml;their respective t max were(0.57±0.24)h and(0.66±0.19)h.The relative bioavailability of testing preparation was(95.62±13.51)%.CONˉCLUSION:The2preparations are bioequivalent.

Key concepts: Bioequivalence, Bioavailability, Cefaclor, Chromatography, Chemistry, High-performance liquid chromatography, Pharmacokinetics, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Relative Bioavailability of Cefaclor Capsules in Human Body — Research Paper | ScholarLens